RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Here's the filing from Edgar Online (see below).

Dreaming up a few far out conspiracy theories, perhaps Mansbach's former employer Glaxo is about to do a BP deal or buyout of Cortex, and having previously burned his bridges with Glaxo, Mansbach is preemptively heading for the exits. OK, it's not very likely, but Glaxo is one of the companies challenging Cortex's Euro patent.


>>> 14-Dec-2006

Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective December 15, 2006, Harry H. Mansbach, M.D., Vice President of Clinical Development, will leave Cortex to pursue another business opportunity. The company plans to re-fill this position in the near future and use the consulting services of one of its board members, Dr. Gary Tollefson, M.D., Ph.D. for support of any near term medical services. <<<